Fecal Calprotectin Testing Market Trends

  • Report ID: 4060
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Fecal Calprotectin Testing Market Trends

Growth Drivers

  • Rising Prevalence of Gastrointestinal Illnesses Among the Global Population – As a result of an unhealthy lifestyle, a lot of people nowadays are suffering from gastrointestinal diseases. Hence, the demand for fecal calprotectin testing is projected to grow during the forecast period. A recent report of 2022 stated that around 60 to 70 million Americans suffer from gastrointestinal diseases every year which cause serious problems in day-to-day life.

  • Growing Focus on Enhancing Medical Devices – Governments of different nations are focusing on developing novel medical equipment for enhanced fecal calprotectin testing for patients. Thus, the increase in investments is attributed to creating a positive outlook for market expansion in the next few years. For instance, a recently published report stated that in India, foreign investments in the medical devices sector increased from USD 301 million in FY20 to USD 151 in FY19.

  • Increasing Burden of Digestive Disorders – According to a report shared by the Centers for Disease Control and Prevention (CDC) it has been revealed that in the North American region, the number of visits to a physician regarding an issue with the digestive system totaled up to approximately 35.4% million in 2019.

  • Burgeoning Geriatric Cases – As a person ages, the body weakens and the body parts start to deteriorate. As a result, the geriatric population is more prone to intestine problems such as colorectal cancers, and colon and rectum cancer. Hence, the expansion of the geriatric population is expected to increase the utilization rate of fecal calprotectin testing in the analysis period. The World Health Organization stated that by 2030, one out of six people in the world is bound to age 60 years and over.

Challenges

  • High Cost of Fecal Calprotectin Testing – As fecal calprotectin testing requires technologically advanced products, the overall cost of fecal calprotectin testing increases. Thus, the population with low and middle income are not able to opt for fecal calprotectin testing which subsequently lowers the adoption rate and hinders the expansion of the market size during the forecast period.
  • Low Awareness Level Among the Population About the Advantages
  • Stringent Government Rules

Fecal Calprotectin Testing Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~12%

Base Year Market Size (2022)

~ USD 180 Million

Forecast Year Market Size (2035)

~ USD 350 Million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Base Year

2024

Forecast Year

2025-2037

CAGR

10.9%

Base Year Market Size (2024)

USD 145.44 million

Forecast Year Market Size (2037)

USD 473.1 million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4060
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of fecal calprotectin testing is assessed at USD 158.24 million.

The fecal calprotectin testing market size was valued at USD 145.44 million in 2024 and is set to reach USD 473.1 million by the end of 2037, expanding at around 10.9% CAGR during the forecast period i.e., between 2025-2037. Increasing prevalence of colorectal cancer and other gastrointestinal diseases will boost the market growth.

North America is projected to hold the largest industry share by 2037, propelled by increasing frequency of colorectal cancer, celiac disease, and other disorders in developed countries.

The major players in the market include Exelixis Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbexa Limited, Bioserv Diagnostics Gmbh, Epitope Diagnostics, Inc., LifeSpan BioSciences, Inc., RayBiotech, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample